Literature DB >> 9839173

Perforin and Fas pathways of cytotoxic T-cells in histiocytic necrotizing lymphadenitis.

K Ohshima1, K Shimazaki, T Kume, J Suzumiya, M Kanda, M Kikuchi.   

Abstract

AIMS: Cell death can be divided into necrosis and apoptosis. In histiocytic necrotizing lymphadenitis (HNL), apoptosis is the main form of cell death. Two molecular mechanisms of T-cell-mediated cytotoxicity, one perforin-based and the other Fas-based, have been demonstrated, and both systems induce apoptosis of the target cells. This study was designed to investigate the Fas and perforin pathways in HNL. METHODS AND
RESULTS: Twelve cases of HNL were analysed using immunohistochemical staining. The Fas and/or FasL-positive cells, including lymphocytes and histiocytes, were frequently encountered in the necrotizing lesions, however, they were rare in the nonpathological regions. The perforin and/or granzyme-positive cells were also confined in the necrotizing lesions. In double staining, CD8-positive lymphocytes occasionally expressed Fas and/or FasL, and histiocytes also expressed FasL and/or Fas. However, CD4-positive lymphocytes rarely expressed FasL and/or Fas. In a flow cytometric analysis, most of the cytotoxic T-cells, which were recognized by cytolytic granules of TIA-1 and considered to be CD8-positive lymphocytes, expressed FasL and Fas. The perforin-positive lymphocytes also expressed FasL and Fas.
CONCLUSION: In our previous study, the apoptotic cells were T-cells, especially CD8-positive cells rather than CD4-positive cells. Based on these findings, in Fas and perforin pathways, the CD8-positive cells were considered to be effector and target cells, while histiocytes could possibly be enhancers. As a result, both pathways seemed to induce an abundance of apoptosis and thus induce necrotizing lesions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9839173     DOI: 10.1046/j.1365-2559.1998.00532.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  15 in total

1.  Involvement of DNase gamma in apoptotic DNA fragmentation in histiocytic necrotizing lymphadenitis.

Authors:  Yoshikazu Higami; Kazuo To; Hiroshi Ohtani; Kenta Masui; Keisuke Iwasaki; Daisuke Shiokawa; Sei-Ichi Tanuma; Isao Shimokawa
Journal:  Virchows Arch       Date:  2003-06-12       Impact factor: 4.064

2.  A Case of Kikuchi's Disease Presenting with Unique Facial Involvement.

Authors:  Young Soo Heo; Soo Bin Son; Jeong Eun Kim; Chil Hwan Oh; Hae Jun Song
Journal:  Ann Dermatol       Date:  2010-05-18       Impact factor: 1.444

3.  Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathy.

Authors:  S A Pileri; F Facchetti; S Ascani; E Sabattini; S Poggi; M Piccioli; D Rondelli; F Vergoni; P L Zinzani; P P Piccaluga; B Falini; P G Isaacson
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

4.  Expression of apoptosis-associated protein RCAS1 in macrophages of histiocytic necrotizing lymphadenitis.

Authors:  Yasunobu Abe; Koichi Ohshima; Manabu Nakashima; Keiichi Hara; Takamitsu Matsushima; Ilseung Choi; Junji Nishimura; Masahiro Kikuchi; Hajime Nawata; Takeshi Watanabe; Koichiro Muta
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

5.  A non-invasive diagnosis of histiocytic necrotizing lymphadenitis by means of gene expression profile analysis of peripheral blood mononuclear cells.

Authors:  Masataka Ishimura; Hiroyuki Yamamoto; Yumi Mizuno; Hidetoshi Takada; Motohiro Goto; Takehiko Doi; Takayuki Hoshina; Shouichi Ohga; Koichi Ohshima; Toshiro Hara
Journal:  J Clin Immunol       Date:  2013-04-23       Impact factor: 8.317

Review 6.  Kikuchi-Fujimoto disease.

Authors:  Xavier Bosch; Antonio Guilabert
Journal:  Orphanet J Rare Dis       Date:  2006-05-23       Impact factor: 4.123

7.  A kikuchi-fujimoto disease case mimicking T cell lymphoma with prolonged Fever.

Authors:  Serap Yadigar; Ilker Inanc Balkan; Nese Saltoglu
Journal:  Case Rep Med       Date:  2014-12-09

8.  Necrotizing cervical lymphadenopathy: Kikuchi-Fujimoto disease in a young male.

Authors:  Marjana Glaser; Peter Borin; Rajko Kavalar; Marjan Skalicky
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 2.275

9.  Kikuchi fujimoto disease.

Authors:  Al-Bishri Jamal
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2012-07-03

10.  The kikuchi-fujimoto disease in Nigeria: a case report and literature review.

Authors:  Akinsegun Akinbami; Mojeed Odesanya; Sunday Soyemi; Sarah John-Olabode; Adewumi Adediran; Olajumoke Oshinaike; Ebele Uche; Adedoyin Dosunmu; Akinola Dada; Olaitan Okunoye
Journal:  Case Rep Med       Date:  2014-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.